Doctors in China — Page 9

Wei Wei is a specialist at Sun Yat-sen University Cancer Center, where he is Chief Physician and Assistant President in Liver Surgery. He focuses on liver cancer and hepatocellular carcinoma (HCC) and performs liver resection. His publications include hepatocellular carcinoma outcome studies in Br J Cancer (2014) and Med Oncol (2013).

Mingtian Yang is a specialist at Sun Yat-sen University Cancer Center and Chief Specialist of Breast Oncology (as of May 2014). He has extensive experience treating esophageal cancer, lung cancer, mediastinal tumors, and breast cancer. His background includes serving as Vice Director of the Thoracic Surgery Department from 1992 to 2006, supporting a thoracic-to-breast oncology perspective.

Mai Haiqiang is a specialist at Sun Yat-sen University Cancer Center, where he is Professor, Chief Physician, and Director of the Department of Nasopharyngeal Carcinoma. He serves as a doctoral advisor and is listed as an editorial board member. His clinical focus is nasopharyngeal carcinoma care.

Liu Mengzhong is a specialist at Sun Yat-sen University Cancer Center, where he is Chief of the Department of Radiation Oncology. He completed clinical medicine training in 1983 and obtained a master’s degree in Clinical Oncology in 1988. His radiation oncology work includes treatment of nasopharyngeal cancer, and he is a member of the Chinese Society of Radiation Oncology.

Lin Wenqian is a specialist at Sun Yat-sen University Cancer Center, working in Anesthesiology with over 20 years of experience in clinical anesthesia and pain treatment. He has handled more than 6,000 cases of clinical anesthesia and is skilled in critical illness first aid. His anesthesia practice includes anesthesia for tumor surgeries and management of critically ill patients.

Li Zhang is a specialist at Sun Yat-sen University Cancer Center, where he is Professor and PhD Supervisor and Deputy Director of the Lung Cancer Research Institute. With over 40 years in medical oncology at the center, he leads precision oncology and drug development research for lung cancer and nasopharyngeal carcinoma (NPC), including Phase I–III trials for ADCs, bispecific antibodies, and immunotherapies. His supportive care research includes cancer pain management and prevention of chemotherapy-induced nausea.